No Picture
News

Eiger BioPharmaceuticals Provides Update on Clinical Development Activities and Business Operations During COVID-19 Pandemic

– HDV Phase 3 D-LIVR Study Progressing; Impact to Timeline- Peginterferon Lambda Investigator-Sponsored Studies in COVID-19 Initiating

PALO ALTO, Calif., April 1, 2020 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the deve… […]

No Picture
News

Eiger BioPharmaceuticals Provides Update on Clinical Development Activities and Business Operations During COVID-19 Pandemic

– HDV Phase 3 D-LIVR Study Progressing; Impact to Timeline- Peginterferon Lambda Investigator-Sponsored Studies in COVID-19 Initiating

PALO ALTO, Calif., April 1, 2020 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the deve… […]

No Picture
News

Eiger BioPharmaceuticals Provides Update on Clinical Development Activities and Business Operations During COVID-19 Pandemic

– HDV Phase 3 D-LIVR Study Progressing; Impact to Timeline- Peginterferon Lambda Investigator-Sponsored Studies in COVID-19 Initiating

PALO ALTO, Calif., April 1, 2020 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the deve… […]

No Picture
News

Eiger BioPharmaceuticals Provides Update on Clinical Development Activities and Business Operations During COVID-19 Pandemic

– HDV Phase 3 D-LIVR Study Progressing; Impact to Timeline- Peginterferon Lambda Investigator-Sponsored Studies in COVID-19 Initiating

PALO ALTO, Calif., April 1, 2020 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the deve… […]

No Picture
News

Eiger BioPharmaceuticals Provides Update on Clinical Development Activities and Business Operations During COVID-19 Pandemic

– HDV Phase 3 D-LIVR Study Progressing; Impact to Timeline- Peginterferon Lambda Investigator-Sponsored Studies in COVID-19 Initiating

PALO ALTO, Calif., April 1, 2020 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the deve… […]

No Picture
News

Largest European Life Science Organization has Selected the ValGenesis SaaS Platform to Digitize Validation Processes Across Global Sites

SAN FRANCISCO, March 30, 2020 /PRNewswire/ — ValGenesis, Inc., a market leader in Enterprise Validation Lifecycle Management solutions today announced that a global biotechnology/chemical and pharmaceutical giant based in Europe has chosen ValGenes… […]